SOURCE: Quture, Inc.

September 06, 2011 08:00 ET

Quture / TCLN Announces Commencement of Demonstration Project at Jackson Memorial Hospital, University of Miami

Quture's "Transformative and Disruptive" Products to Become New Standard for Global Performance Measurement

WEST PALM BEACH, FL--(Marketwire - Sep 6, 2011) - Techs Loanstar, Inc. (OTCQB: TCLN) (PINKSHEETS: TCLN) and Quture, Inc. ("Quture") announced the commencement of their Demonstration Project at Jackson Memorial Hospital, University of Miami. The Demonstration Project is one of the final steps in formally launching their new "transformative and disruptive" tool that improves health care while reducing costs.

Quture's technology, announced on August 23, 2011, is in the final stages of demonstrating its value for ROI. The Company is leveraging its former clinical peer review product to exceed the new mandated requirements for performance measurement and value-based purchasing. Quture's product promises to be the new performance measurement standard as CMS (Medicare/Medicaid) and private payers change from the inefficient payment system based on fee-for-service to fee-for-value.

The goal of achieving optimal health in the United States care has been compromised in the past because software tools were based on billing codes, not clinical data that analyzes quality. Quture's tool connects real clinical quality data from multiple vendor sources while integrating true cost data, not charge-based data. This demonstration of Quture's new tool will culminate within several months with the potential to empower hospitals to improve clinical processes of care and reduce costs while improving revenue. Quture's technology focuses on the quality and cost of treating an individual patient in a patient-centered value model as recently proposed by the authors of the Harvard Business Review article, "Three Myths About Health Care Exploded" (September 2011).

"We are nearing announcement of our first newly enhanced product to connect true clinical quality with value," said Landon Feazell, CEO of Quture. "Healthcare providers know that existing quality of care and patient safety products do not work. The evidence of rates of adverse events and medical errors speak for themselves while costs continue to spiral out of control. Our new product will finally connect quality and costs of care. The product will deliver the promise of our work on the 'quality-value proposition' as published in 2003 in Healthcare Finance Journal. We are leveraging the lessons learned from over 35 years of measuring performance manually and converting them into an electronic system that can provide real-time clinical knowledge and insight to doctors, nurses and hospitals as never before. Our years of developing clinical content and utilizing a new technology platform will finally achieve its potential. This is a significant milestone in the evolution of our now publicly traded company."

The Project is designed by Keith A. Candiotti, M.D., Chief, Division of Perioperative Medicine and Director of Clinical Research, Department of Anesthesiology, Jackson Memorial Hospital and University of Miami Miller Medical School. The demonstration connects individual patient risk factors with evidence-based perioperative performance measures compared to patient outcomes. The impact of compliance on outcomes and costs associated with extended stays and complications in recovery and beyond for well-established performance measures in anesthesia connects clinical quality with outcomes and costs.

Added Feazell: "It is truly remarkable that years of development of intellectual property and clinical content are now converging on an extraordinary technology platform to derive clinical knowledge solutions. Dr. Janice Ophoven, Chief Medical Officer of Quture and her team have worked with us all these years to develop these assets, which can now be deployed on the best technology platform available to health care and is fully developed and deployed to satisfy our requirements and specifications. We believe we can solve the problems of disparate databases and silos of information that have limited our endeavors for over 35 years of clinical performance measurement in health care. This is a pivotal juncture in health care, its impact on the American economy and on the lives of patients and the professionals devoted to caring for them. We will be proud to introduce these new tools to accomplish our mission and to exceed and bring new capability to the extensive new federal and national mandates and standards."

About Quture

Quture, Inc., a Nevada corporation, is positioned to rapidly become the international standard in healthcare performance and outcomes measurement and analytics to accomplish its corporate mission. Quture provides healthcare organizations, insurers, government payers, and other stakeholders in the healthcare community with performance measurement tools and data sets. Industry experts agree that performance and outcomes measurement is the "transformative tool" to reduce medical cost and improve quality of care. Quture's management team has 35 years of experience and a long history of working with many of the nation's leading healthcare institutions as a leader and innovator in measuring clinical performance. Quture is now testing its revolutionary solution to effectively and efficiently measure clinical performance from multiple vendor databases.

Forward-Looking Statements

This release contains forward-looking statements, including, without limitation, statements concerning our business and possible or assumed future results of operations. Our actual results could differ materially from those anticipated in the forward-looking statements for many reasons including: our ability to continue as a going concern, adverse economic changes affecting markets we serve; competition in our markets and industry segments; our timing and the profitability of entering new markets; greater than expected costs, customer acceptance of our products or difficulties related to our integration of the businesses we may acquire; and other risks and uncertainties as may be detailed from time to time in our public announcements and SEC filings. Although we believe the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made, and our future results, levels of activity, performance or achievements may not meet these expectations. We do not intend to update any of the forward-looking statements after the date of this document to conform these statements to actual results or to changes in our expectations, except as required by law.

Contact Information

  • For Further Information Contact:
    Constellation Asset Advisors, Inc.
    Jens Dalsgaard
    President
    +1 (415) 524-8500